Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
06/11/2008 | CN100393347C Vaginitis treating Chinese medicine composition and its preparation |
06/11/2008 | CN100393345C Oral preparation for treating gynecopathy |
06/11/2008 | CN100393317C Polyene phosphatidyl choline infusion solution and its preparing method |
06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
06/10/2008 | US7384971 Phytochemicals for the treatment of cervical dysplasia |
06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
06/10/2008 | US7384943 Substituted chroman derivatives |
06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
06/05/2008 | WO2008066117A1 Cyclic amine compound |
06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
06/05/2008 | US20080132473 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology |
06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
06/05/2008 | US20080131494 Dermal Penetration enhancers and drug delivery systems involving same |
06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
06/05/2008 | CA2670976A1 Cyclic amine compound |
06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
06/04/2008 | EP1926742A1 Cell surface coating with hyaluronic acid oligomer derivative |
06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
06/04/2008 | EP1343775B1 Piperazine derivatives |
06/04/2008 | EP1292607B1 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl -17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one |
06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
06/04/2008 | CN101193639A Tanaproget compositions containing ethinyl estradiol |
06/04/2008 | CN101193631A Inhibitors of soluble adenylate cyclase |
06/04/2008 | CN101190327A í«Kanlijiaobuyeí» a kind of traditional Chinese medicinal oral liquid |
06/04/2008 | CN101190325A Traditional Chinese medicine composing prescription for treating obstructed fallopian tubes |
06/04/2008 | CN101190310A Traditional Chinese medicine composition for treating mazopathy |
06/04/2008 | CN101190309A Traditional Chinese medicine for treating perimenopause syndrome |
06/04/2008 | CN101190297A Traditional Chinese medicine compound preparations for preventing and controlling abnormal uterine bleeding after medical abortion |
06/04/2008 | CN101190291A í«Tianjingzhongzigaoí» (an externally-applied plaster) special for treating soreness and weakness of the loins and knees |
06/04/2008 | CN101190265A Medicine for treating endometriosis and preparation method thereof |
06/04/2008 | CN101190181A Monomer nano silver sanitary tampon and preparation method thereof |
06/04/2008 | CN100391933C Substituted 1-aminobutan-3-01 derivatives |
06/04/2008 | CN100391544C The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
06/04/2008 | CN100391532C Ointment of treating dysmenorrhea, its preparing method and quality control method |
06/04/2008 | CN100391504C Pharmaceutical composition for treating sexual disorder and its preparation process |
06/04/2008 | CN100391482C Saussurea involucrate powder injection |
06/04/2008 | CN100391449C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
06/04/2008 | CA2568512A1 Gender selection with the use of antibodies |
06/03/2008 | US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
06/03/2008 | US7381704 Methods for use of short bioactive peptides |
06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
05/29/2008 | WO2008064217A2 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
05/29/2008 | WO2008061456A1 The folacin-metformin compound and its manufacture |
05/29/2008 | WO2008024026A3 Use of 9-oxoacridine-10-acetic acid, its salts and esters for the treatment, prophylaxis or relapse prevention of prostate cancer |
05/29/2008 | WO2007143423A3 Treatment of hot flashes using muscarinic receptor antagonists such as oxybutynin |
05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
05/29/2008 | US20080125477 7-(acryloyl) indole compositions and methods of making and using same |
05/29/2008 | US20080125463 2-Bromo-N-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-benzamide; fertility disorders, menstrual pains, endometriosis, pain, cancer, osteoporosis |
05/29/2008 | US20080125435 E. g., 1-(3-chloro-phenyl)-3-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-thiourea; regulation of ovulation, modulation of prostaglandin E2 receptors; fertilization, nidation, decidualization (e.g. placenta formation) and menstruation; hypermenorrhea, dysmenorrhea; endometriosis; anticarcinogenic agents |
05/29/2008 | US20080125402 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
05/29/2008 | US20080125401 Use of estradiol valerate or 17beta-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido |
05/29/2008 | US20080125391 administering to a mammal harboring a tumor which expresses HALRs, a Sindbis virus vector to treat the tumor, and the vector has not been modified to target a tumor-specific cellular determinant, has a preferential affinity for HALRs, a Sindbis virus E2 HALR binding domain; ganciclovir; gene therapy |
05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
05/29/2008 | US20080124380 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
05/29/2008 | US20080124347 Insulinotropic peptide conjugate using carrier substance |
05/28/2008 | EP1925316A2 Compositions for treating vaginal, cervical and uterine epithelial lesions |
05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
05/28/2008 | EP1925307A1 Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
05/28/2008 | EP1924251A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |
05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
05/28/2008 | EP1343806B1 Methylene steroids as novel androgens |
05/28/2008 | EP1313766B1 Coaster, a human coactivator of steroid receptors |
05/28/2008 | EP1220675B1 Hormone-sensitive lipase activity mediated male infertility |
05/28/2008 | CN101189015A 延长的雌激素定量给药避孕疗法 Prolonged estrogen therapy dosing contraceptive |
05/28/2008 | CN101186925A General-purpose highly effective eukaryon expression carrier p3I-GFPN and mastitis-resisting transgene carrier constructed by the same |
05/28/2008 | CN101185738A Gynaecologic inflammation rehabilitation effervescence granular preparation and confecting method thereof |
05/28/2008 | CN101185735A Compound breast-rounding essential oil |
05/28/2008 | CN101185727A Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
05/28/2008 | CN101185711A Nucleus eliminating ointment special for treating hyperplasia of mammary glands |
05/28/2008 | CN101185702A Medicine for treating gynaecologic inflammation |
05/28/2008 | CN101185659A Intermediate compound of a traditional Chinese medicinal preparation and preparation method and application thereof |
05/28/2008 | CN101185658A Intermediate compound of a liquid state traditional Chinese medicinal preparation and preparation method and application thereof |
05/28/2008 | CN100389815C Medicine for treating mammary glands hyperplasia |
05/28/2008 | CN100389789C Preparation method of capsule containing red sage root and notoginseng |
05/28/2008 | CN100389769C Compound water soluble preparation of domperidone and crotamiton and production thereof |
05/28/2008 | CN100389766C Pharmaceutical use of dihydro myricetin |
05/28/2008 | CN100389763C Lactic acid , glycerin formulation for female vagina acidity, humidity improvement |
05/28/2008 | CN100389758C Preparation method of nonoxinol foamable composition and its quality control method |
05/28/2008 | CN100389755C Compositions and methods for mucosal delivery |
05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |